Late toxicities, long-term follow-up, less intensive treatment: leading issues in the therapy of testis cancer

J Clin Oncol. 1988 Aug;6(8):1216-9. doi: 10.1200/JCO.1988.6.8.1216.

Authors

P W Kantoff¹, M B Garnick

Affiliation

¹ Dana-Farber Cancer Institute, Harvard Medical School, Boston.

PMID: 2842462
DOI: 10.1200/JCO.1988.6.8.1216

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Follow-Up Studies
Humans
Male
Neoplasms, Germ Cell and Embryonal / drug therapy*
Testicular Neoplasms / drug therapy*